Informed Consent as Patient Driven Policy for Clinical Diagnosis and Treatment: A Smart Contract Based Approach

被引:2
|
作者
Al Amin, Md [1 ]
Altarawneh, Amani [1 ]
Ray, Indrajit [1 ]
机构
[1] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA
来源
PROCEEDINGS OF THE 20TH INTERNATIONAL CONFERENCE ON SECURITY AND CRYPTOGRAPHY, SECRYPT 2023 | 2023年
基金
美国国家科学基金会;
关键词
Informed Consent; Patient; Provider; Clinical Treatment; Disease Diagnosis; Blockchain; Smart Contract; ELECTRONIC HEALTH RECORD;
D O I
10.5220/0012090600003555
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Digitized healthcare systems improve services, make it easier for healthcare providers to work together, improve the accuracy of diagnoses, and get the most out of each treatment. They provide healthcare services that are better, faster, more reliable, and less expensive. With the help of information technology, computing resources, and digitized health records, medical researchers are trying to solve critical health problems like COVID-19. However, electronic healthcare systems significantly risk patients' data privacy and security. Anyone with credentials can access patients' healthcare data. Patients grant consent to share or access data. But they need a way to ensure informed consent is done right and on time. Due to the centralized authority in present healthcare systems, healthcare-covered entities perform all operations. As a result, many unwanted events and security incidents happen in healthcare systems. Patients must know how their data is accessed, by whom, and when. Therefore, a blockchain and smart contract-based patient-informed consent management system is proposed. Where patients provide informed consent to share or access their health records, as well as methods to ensure that informed consent is properly completed. The immutability and auto-triggering properties of blockchain and smart contracts ensure the integrity and accountability of the given informed consent.
引用
收藏
页码:159 / 170
页数:12
相关论文
共 50 条
  • [21] Patient reported measures of informed consent for clinical trials: A systematic review
    Gillies, Katie
    Duthie, Alexander
    Cotton, Seonaidh
    Campbell, Marion K.
    PLOS ONE, 2018, 13 (06):
  • [23] Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis
    Criscione, LG
    Sugarman, J
    Sanders, L
    Pisetsky, DS
    St Clair, EW
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (03): : 361 - 367
  • [24] Prospective and observational study of the patient informed consent for clinical trials with drugs
    Ordovas Baines, Juan Pablo
    MEDICINA CLINICA, 2008, 131 (11): : 422 - 425
  • [25] Informed consent in oncology clinical trials in Brazil: Patient's perceptions
    Viegas, MAV
    Marques, JC
    PSYCHO-ONCOLOGY, 1999, 8 (06) : 18 - 18
  • [26] A stakeholder-driven approach to improve the informed consent process for palliative chemotherapy
    Enzinger, Andrea C.
    Wind, Jennifer K.
    Frank, Elizabeth
    McCleary, Nadine J.
    Porter, Laura
    Cushing, Heather
    Abbott, Caroline
    Cronin, Christine
    Enzinger, Peter C.
    Meropol, Neal J.
    Schrag, Deborah
    PATIENT EDUCATION AND COUNSELING, 2017, 100 (08) : 1527 - 1536
  • [27] CONSENT: Randomized controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials
    Pal, Abhijit
    Daly, Robert
    Stapleton, Sarah
    Yap, Christina
    Hong, Martin
    Grochot, Rafael
    MohamedKhan, Shybi
    Lai-Kwon, Julia Elizabeth
    Magkos, Dimitrios
    Baikady, Bindumalini Rao
    Minchom, Anna Rachel
    Banerji, Udai
    De Bono, Johann S.
    Karikios, Deme John
    Boyle, Frances M.
    Lopez, Juanita Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Informed consent and childhood gender dysphoria: emerging complexities in diagnosis and treatment
    d'Abrera, Juan Carlos
    D'Angelo, Roberto
    Halasz, George
    Prager, Shirley
    Morris, Philip
    AUSTRALASIAN PSYCHIATRY, 2020, 28 (05) : 536 - 538
  • [29] POLICY OF FOOD AND DRUG ADMINISTRATION ON INFORMED CONSENT - FROM A CLINICAL PHARMACOLOGISTS VIEWPOINT
    SILSON, JE
    JOURNAL OF NEW DRUGS, 1966, 6 (06): : 313 - &
  • [30] A Contract Law Approach for the Treatment of Smart Contracts' 'Bugs'
    Rizos, Evripidis
    EUROPEAN REVIEW OF PRIVATE LAW, 2022, 30 (05): : 775 - 801